A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
Clinical trial NCT03706365 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03706365
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2024-01-02
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.